PFF Clinical Trial Innovation (CTI) Webinar Series June 2026 | Virtual
Please join the Pulmonary Fibrosis Foundation (PFF) and industry representatives for the PFF Clinical Trial Innovation (CTI) Webinar Series on Tuesday, June 23, 2026. You will learn about the development of innovative therapies and advancements in pulmonary fibrosis (PF) and interstitial lung disease (ILD) research.
Boehringer Ingelheim
- Trial Title | A study to find out whether BI 765423 has an effect on lung function in people with idiopathic pulmonary fibrosis (IPF) with or without standard treatment
- Speaker | Nina Patel, MD; Clinical Program Lead at Boehringer Ingelheim
MannKind
- Trial Title | INFLO-1 and INFLO-2
- Speaker | Wassim Fares, MD, MSc, FCCP; Therapeutic Area Head – Respiratory at MannKind
Trevi Therapeutics
- Trial Title | OCEAN-1: A Phase 3 Chronic Cough Trial in Patients with IPF
- Speaker | Ross Summer, MD; CEO, Jane & Leonard Korman Respiratory Institute, Ludwig Kind Professor of Medicine, Division Chief, Pulmonary, Allergy and Critical Care Medicine
DISCLAIMER: Participation in the CTI Webinar Series and references to specific commercial entities (companies) or products do not reflect endorsement by the PFF. The PFF does not endorse or promote any products or services participants discuss in the CTI Webinar Series, and participants cannot suggest otherwise. Please note that any information contained in this presentation is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider to determine if a clinical trial is right for you.